跳至主要内容
临床试验/ISRCTN66923582
ISRCTN66923582已完成未知

rinary Biomarker URO17 Study

Cardiff University0 个研究点目标入组 500 人开始时间: 2021年6月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Participant is willing and able to give informed consent
  • 2. Attending Rapid Access Haematuria Clinic (RAHC) for further investigation for suspected bladder cancer
  • 3. Patients aged >18 years with either visible haematuria or with symptomatic LUTS associated with non-visible haematuria

排除标准

  • 1. Participant unable to give informed consent
  • 2. Previous history of urinary tract malignancy
  • 3. Previous history of pelvic radiotherapy
  • 4. Active urine infection
  • 5. Be currently taking investigational drugs or actively participating in a treatment trial for any condition
  • 6. Be an employee of the study site or the sponsor
  • 7. Have a medical condition or serious intercurrent illness, or other circumstance that, in the Investigator’s judgment, could jeopardize the candidate’s safety as a study subject, or that could interfere with study objectives

研究者

相似试验